These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1940400)

  • 21. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.
    Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D; Epstein M; Lan L; Tan P; Booker J
    Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reduction of thyroid volume following radioiodine therapy for functional autonomy].
    Luster M; Jacob M; Thelen MH; Michalowski U; Deutsch U; Reiners C
    Nuklearmedizin; 1995 Apr; 34(2):57-60. PubMed ID: 7761274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism.
    Kung AW; Pun KK; Lam KS; Choi P; Wang C; Yeung RT
    Q J Med; 1990 Sep; 76(281):961-7. PubMed ID: 2236479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
    Vijayakumar V; Ali S; Nishino T; Nusynowitz M
    Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
    Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of long-term follow-up after compensated fixed-dose therapy for thyrotoxicosis.
    Zaini A; Khir A; Doi SA; Chan SP; Paramsothy M; Khoo BH
    J Int Med Res; 1992 Jun; 20(3):279-88. PubMed ID: 1397673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothyroidism following radioiodine treatment of thyrotoxicosis.
    Staffurth JS
    J R Coll Physicians Lond; 1987 Jan; 21(1):55-7. PubMed ID: 3820156
    [No Abstract]   [Full Text] [Related]  

  • 31. Radioiodine therapy in benign thyroid disorders. Evaluation of French nuclear medicine practices.
    Bernard D; Desruet MD; Wolf M; Roux J; Boin C; Mazet R; Gallazzini C; Calizzano A; Vuillez JP; Allenet B; Fagret D
    Ann Endocrinol (Paris); 2014 Sep; 75(4):241-6. PubMed ID: 25156133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional autonomies of thyroid and efficacy of radioiodine therapy.
    Kraft O; Stepien A
    Cancer Biother Radiopharm; 2007 Apr; 22(2):261-7. PubMed ID: 17600474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Follow-up results of 131-I therapy of benign thyroid diseases: an unsolved problem of dosimetry].
    Falkensammer M; Ladurner D; Riccabona G
    Strahlentherapie Sonderb; 1975; 74():64-73. PubMed ID: 1198676
    [No Abstract]   [Full Text] [Related]  

  • 34. [Radioiodine therapy of thyrotoxicosis in a central hospital].
    Sonne HS; Larsen B; Asfeldt VH
    Ugeskr Laeger; 1993 Oct; 155(43):3483-6. PubMed ID: 8256341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioiodine-131 treatment of thyrotoxicosis: dose required for and some factors affecting the early induction of hypothyroidism.
    Alevizaki CC; Alevizaki-Harhalaki MC; Ikkos DG
    Eur J Nucl Med; 1985; 10(9-10):450-4. PubMed ID: 4006987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of treatment of thyrotoxicosis by three different methods.
    Franklyn JA; Daykin J; Drolc Z; Farmer M; Sheppard MC
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):71-6. PubMed ID: 2004475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of radioiodine therapy on thyroid nodule size and function in patients with toxic adenomas.
    Erdoğan MF; Küçük NO; Anil C; Aras S; Ozer D; Aras G; Kamel N
    Nucl Med Commun; 2004 Nov; 25(11):1083-7. PubMed ID: 15577585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal study of changes in body mass index and total body composition after radioiodine treatment for thyrotoxicosis.
    de la Rosa RE; Hennessey JV; Tucci JR
    Thyroid; 1997 Jun; 7(3):401-5. PubMed ID: 9226210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient hypothyroidism following radioiodine therapy for thyrotoxicosis.
    Connell JM; Hilditch TE; McCruden DC; Alexander WD
    Br J Radiol; 1983 May; 56(665):309-13. PubMed ID: 6850213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioactive iodine for thyrotoxicosis in childhood and adolescence: treatment and outcomes.
    Namwongprom S; Unachak K; Dejkhamron P; Ua-apisitwong S; Ekmahachai M
    J Clin Res Pediatr Endocrinol; 2013; 5(2):95-7. PubMed ID: 23748061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.